As the confected Covid scare recedes into the rear-view mirror, the cleaning up operation moves into high gear, as the guilty men (and women) seek to remove from the record all trace of their hysterical folly.
We’ve had the quiet rescinding of the approval of the Astra-Zeneca ‘vaccine’. That took place some months ago. Did you hear about it on the ABC? Me neither. Perhaps I missed it – to be fair, I’m no longer the avid watcher of the ABC ‘News’ that I once was. No doubt the MRNA ‘vaccines’, which are already acknowledged to inflict injuries at a rate several times that which has caused therapies operating under pre-madness conditions to be denied approval, will follow soon enough.
Now it’s the turn of Ivermectin. Remember Ivermectin? The fabulously effective treatment for parasites, of which literally billions of doses have been associated, inn decades of use, with a but few handfuls of adverse reactions. Early on in the Covid panic, there was good evidence that it might be repurposed to both prevent and treat Covid infection. Dutch hospitals used it, and reported a reduction in infections among staff and a lower rate of ICU transfer among patients. The home treatment kits issued to Indians contained Ivermectin, and their distribution was followed by a drastic drop in Covid infections.
There was, in short, good reason to suspect that Ivermectin might reduce the risk posed by Covid, already greatly exaggerated, to the level of a common cold, and no reason at all to suspect that even if it didn’t, it posed a risk to those who took it in the recommended doses.
There were, however, a couple of problems.
In the first place, Ivermectin is out of patent. It’s made by the ton in India, and it’s dirt cheap. So the people who first made it, Merck, have not the slightest interest in researching its effectiveness as a treatment for Covid.
Secondly, having invested a great deal of reputation and effort in scaring everybody witless, ruining the economy and hollering for a ‘vaccine’ solution to the crisis they had persuaded everybody was upon us, our health authorities were not about to see their parade rained on by a cheap, readily-available treatment.
So, to save face, they simply banned its prescription for Covid treatment. The reasons the TGA gave were barely coherent:
Apparently, people were starting to use it in quantities far exceeding the recommended dosage. So rather than people obtaining it under advice from their doctors, as is the case with the countless other drugs that save lives but can cost them if taken in overdose, the TGA created a situation whereby the many people who had drunk its Koolaid and, in their desperation to combat the dread Covid managed to get hold of a bootleg supply of Ivermectin would henceforth take it without any professional advice at all. Make sense to you? Me neither.
Next, they claimed that people taking what they asserted was an ineffective Covid treatment would be less likely to take their shiny new ‘safe and effective’ ‘vaccines’. With the first of these vaccines, AstraZeneca now withdrawn because it wasn’t safe after all, and evidence growing that the MRNA vaccines deserve the same fate, it’s fair to suggest that many people, properly advised, would have chosen to place their faith in Ivermectin. You be the judge.
Lastly, the TGA made the preposterous claim that supplies of Ivermectin were in danger of running out, threatening its availability to those needing it for its original purpose, treating parasites. Given that it’s made in India in vast quantity and very cheaply, this was an outright lie.
Perhaps because of the rising tide of litigation over official Covid malfeasance, and because someone has looked at this litany of incoherent twaddle and fears that it might not play well in court, the TGA has now reversed its ban. (h/t The Daily Sceptic) So the repurposed, cheap, antiviral that was lethal two years ago is now perfectly safe.
What could possibly have brought about this astonishing change of heart? Well, at the time Ivermectin’s use was being strenuously resisted, Merck was busy developing a shiny new Covid antiviral, Molnupiravir, which it no doubt expected to sell at many times the cost per dose of Ivermectin. Of course, it would be churlish to suggest a connection, and even more churlish to point out that Molnupiravir has since turned out to be a turkey. Professor Mark Morgan, the Chair of Royal Australian College of General Practitioners was blunt:
‘In summary, Molnupiravir did not work. The drug is an antiviral and seems to reduce viral load but that did not translate into saving people from severe disease. I hope patients don’t miss out on effective treatments because of ongoing use of less effective treatments.’ Perhaps Prof Morgan should have had a sharp word with the TGA about Ivermectin?
However, it is worth wondering how many lives were cost by the TGA’s disgraceful politicking. Perhaps, like the consequences of rolling out an experimental gene therapy under the misleading rubric of ‘vaccines’, that question will one day find its way into the courts?